Jagsonpal Pharmaceuticals: Board Meeting Intimation for Proposal Of Buyback Of Equity Shares Of The Company

Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/03/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the Meeting of the Board of Directors of Jagsonpal Pharmaceuticals Limited (the Company) is scheduled to be held on Thursday March 12 2026 to consider and approve the proposal for Buyback of its fully paid-up equity shares of the Company of face value of Rs.2/-¬each and the matters necessary and incidental thereto in accordance with the applicable provisions of the Companies Act 2013 including Rules framed thereunder the Securities and Exchange Board of India (Buyback of Securities) Regulations 2018 as amended and other applicable laws.